Riskpilot← Back to searchSign inGet full accessALGIPHARMA HOLDING AS
ASActiveOrg 920171591Industriveien 33, 1337 SandvikaManufacture of lifting and handling equipment · NACE 2822Est. 20170 employeeswww.algipharma.com
Revenue 2024
NOK 0
EBITDA margin
—
-26% vs 2023
Equity ratio
98.7%
Financial strength
Net profit 2024
NOK -580K
+40% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -199K | -26% |
| Net profit | NOK -580K | +40% |
| Total assets | NOK 203M | +15% |
| Equity | NOK 200,4M | +63% |
| Employees | 0 | — |
Legal name
ALGIPHARMA HOLDING AS
Org number
920171591
Legal form
Aksjeselskap
NACE code
2822 · Manufacture of lifting and handling equipment
Founded
29. desember 2017
Share capital
NOK 2 839 792
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap eller tre styremedlemmer i fellesskap.
Company purpose
Investere i andre selskap som driver forskning og kommersialisering av forskningsprosjekter og forskningsresultater knyttet til alginater og annen bioteknologi og virksomhet i tilknytning til dette.
Address
Industriveien 33, 1337 Sandvika
Website
www.algipharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | −15 | 0 | −52 | −158 | −199 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | −15 | 0 | −52 | −158 | −199 |
| Net financials | 0 | 0 | 0 | 0 | 0 | −689 | −381 |
| Profit before tax | 0 | 0 | −15 | 0 | −52 | −847 | −580 |
| Tax | −0 | −0 | −0 | −0 | −0 | 116 | −0 |
| Net profit | 0 | 0 | −15 | 0 | −52 | −963 | −580 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 30 | 15 | 15 | 15 | 143 621 | 175 919 | 202 969 |
| Equity | 15 | 15 | 0 | 0 | 84 267 | 123 304 | 200 421 |
| Long-term debt | 0 | 0 | 0 | 0 | 59 287 | 51 933 | 2 547 |
| Short-term debt | 15 | 0 | 15 | 15 | 67 | 681 | 0 |
| Total debt | 15 | 0 | 15 | 15 | 59 354 | 52 614 | 2 547 |
EBITDA margin
-19890600.0%
This company
15.8%
Market median
-125889973% vs market
20182024
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
20182024
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20182024
Net profit margin
-57966400.0%
This company
8.1%
Market median
-715634668% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HK Contact Person | Contact Person | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Drammen Slip & Verksted As | Company | 81.6% | 81.6% | 2024 |
| Individual | 67.2% | 67.2% | 2022 | |
Marchmain As | Company | 9.2% | 9.2% | 2024 |
Iff N&H Norway As | Company | 1.7% | 1.7% | 2024 |
Stiftelsen Biopolymer | Company | 1.7% | 1.7% | 2024 |
Dessen Invest As | Company | 1.3% | 1.3% | 2024 |
Løkta As | Company | 1.2% | 1.2% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Frydenberg As
ALGIPHARMA HOLDING AS Board members of ALGIPHARMA HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Kristiansen | Contact Person | 0 companies |
| John Nicholas Ralph Wilkinson | Board of Directors | 0 companies |
| Charles Anthony Cowper Johnson | Board of Directors | 0 companies |
| Tore Paulshus | Chairman | 0 companies |
| Diderik Børsting Schnitler | Board of Directors | 0 companies |
| Arne Dessen | Board of Directors | 0 companies |
| Preston White Campbell Iii | Board of Directors | 0 companies |
| Michael Jeffrey Walters | Board of Directors | 0 companies |
| Yngvar Peter Berg | Chairman | 0 companies |